| scholarly article | Q13442814 |
| P356 | DOI | 10.3109/10641963.2010.549265 |
| P698 | PubMed publication ID | 21649531 |
| P50 | author | Alberto Milan | Q53722529 |
| P2093 | author name string | Cesare Cuspidi | |
| Gian Battista Danzi | |||
| Maria Lorenza Muiesan | |||
| Alberto Morganti | |||
| Carla Sala | |||
| Francesca Negri | |||
| Laura Lonati | |||
| Anna Capra | |||
| Marcella Longo | |||
| Working Group on Heart and Hypertension of the Italian Society of Hypertension | |||
| P2860 | cites work | Left atrial volume and geometry in healthy aging: the Cardiovascular Health Study | Q34143087 |
| The aging process of the heart: obesity is the main risk factor for left atrial enlargement during aging the MONICA/KORA (monitoring of trends and determinations in cardiovascular disease/cooperative research in the region of Augsburg) study | Q35012622 | ||
| Gender differences in the risk of ischemic stroke and peripheral embolism in atrial fibrillation: the AnTicoagulation and Risk factors In Atrial fibrillation (ATRIA) study | Q36255692 | ||
| Does size matter? Clinical applications of scaling cardiac size and function for body size | Q37149720 | ||
| Echocardiographic evaluation of left atrial size and function: current understanding, pathophysiologic correlates, and prognostic implications. | Q37334562 | ||
| Echocardiographic determination of left ventricular mass in man. Anatomic validation of the method | Q39802766 | ||
| Echocardiographic predictors of nonrheumatic atrial fibrillation. The Framingham Heart Study | Q41043329 | ||
| Atrial fibrillation at baseline and during follow-up in ALLHAT (Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial). | Q43238582 | ||
| Echocardiography in clinical practice: the burden of arterial hypertension. A multicenter Italian survey | Q43795578 | ||
| Left atrial size and the risk of stroke and death. The Framingham Heart Study | Q43808183 | ||
| Correlates of left atrial size in hypertensive patients with left ventricular hypertrophy: the Losartan Intervention For Endpoint Reduction in Hypertension (LIFE) Study | Q43920038 | ||
| Impact of atrial fibrillation on mortality, stroke, and medical costs | Q44057872 | ||
| Left atrial volume: a powerful predictor of survival after acute myocardial infarction. | Q44446574 | ||
| Left atrial size in hypertensive men: influence of obesity, race and age. Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents | Q45335362 | ||
| Prevalence and correlates of left atrial enlargement in essential hypertension: role of ventricular geometry and the metabolic syndrome: the Evaluation of Target Organ Damage in Hypertension study | Q46388300 | ||
| Left ventricular mass but not geometry determines left atrial size in the early stages of hypertension | Q47193339 | ||
| Left atrial size and the risk of ischemic stroke in an ethnically mixed population | Q47256099 | ||
| Body mass index is an independent determinant of left atrial size | Q47284347 | ||
| Left atrial size and risk of major cardiovascular events during antihypertensive treatment: losartan intervention for endpoint reduction in hypertension trial | Q47309247 | ||
| Left atrium size and the risk of cardiovascular death in middle-aged men. | Q47372593 | ||
| Relationship between left ventricular geometry and left atrial size and function in patients with systemic hypertension | Q47413723 | ||
| How should left atrial size be reported? Comparative assessment with use of multiple echocardiographic methods | Q47430210 | ||
| Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardio | Q57217547 | ||
| Left atrial remodelling in patients with myocardial infarction complicated by heart failure, left ventricular dysfunction, or both: the VALIANT Echo Study | Q57396270 | ||
| P433 | issue | 5 | |
| P921 | main subject | echocardiography | Q216933 |
| left atrial enlargement | Q6516936 | ||
| P304 | page(s) | 328-335 | |
| P577 | publication date | 2011-06-07 | |
| P1433 | published in | Clinical and Experimental Hypertension | Q5133806 |
| P1476 | title | Prevalence and correlates of echocardiographic left atrial enlargement in hypertensive outpatients in clinical practice. | |
| P478 | volume | 33 |
| Q46703877 | Correlation between CH2DS2-VASc Score and Serum Leptin Levels in Cardioembolic Stroke Patients: The Impact of Metabolic Syndrome. |
| Q87369565 | Evaluation of left atrial function in hypertensive patients with and without left ventricular hypertrophy using velocity vector imaging |
| Q89052357 | Left atrial dimension is related to blood pressure variability in newly diagnosed untreated hypertensive patients |
| Q54781843 | Left atrial enlargement and blood pressure variability in untreated hypertensive patients. |
| Q38079711 | Prevalence of echocardiographic left-atrial enlargement in hypertension: a systematic review of recent clinical studies |
| Q30389039 | Prevalence of left atrial enlargement and its risk factors in general Chinese population |
| Q49557096 | The relation between blood pressure components and left atrial volume in the context of left ventricular mass index. |
| Q26864437 | What do we currently know about metabolic syndrome and atrial fibrillation? |
Search more.